Metabolic Syndrome Market Report

Global and Region Metabolic Syndrome Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：174
  • REPORT CODE：GMM972269
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Metabolic Syndrome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Metabolic Syndromemarket, defines the market attractiveness level of Metabolic Syndrome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Metabolic Syndrome industry, describes the types of Metabolic Syndrome market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metabolic Syndrome market and the development prospects and opportunities of Metabolic Syndrome industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metabolic Syndrome market in Chapter 13.

    By Player:

    • AstraZeneca

    • Novo Nordisk

    • Eli Lily

    • Amicus Therapeutics

    • Sanofi

    • Aegerion Pharmaceuticals

    • Alnylam Pharmaceuticals

    • Arbutus Biopharma

    • Actelion Pharmaceuticals

    • Adocia

    • Merck

    • Amarin

    • nAmgen

    • AbbVie

    • Akros Pharma

    By Type:

    • Diabetes

    • Obesity

    • Hypercholesterolemia

    • Lysosomal storage diseases

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Metabolic Syndrome Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Metabolic Syndrome Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Metabolic Syndrome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Metabolic Syndrome Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Metabolic Syndrome Market Analysis and Outlook to 2022

    • 7.1 Global Metabolic Syndrome Consumption (2017-2022)

    • 7.2 United States Metabolic Syndrome Consumption (2017-2022)

    • 7.3 Europe Metabolic Syndrome Consumption (2017-2022)

    • 7.4 China Metabolic Syndrome Consumption (2017-2022)

    • 7.5 Japan Metabolic Syndrome Consumption (2017-2022)

    • 7.6 India Metabolic Syndrome Consumption (2017-2022)

    • 7.7 South Korea Metabolic Syndrome Consumption (2017-2022)

    8 Region and Country-wise Metabolic Syndrome Market Analysis and Outlook to 2028

    • 8.1 Global Metabolic Syndrome Consumption Forecast (2022-2028)

    • 8.2 United States Metabolic Syndrome Consumption Forecast (2022-2028)

    • 8.3 Europe Metabolic Syndrome Consumption Forecast (2022-2028)

    • 8.4 China Metabolic Syndrome Consumption Forecast (2022-2028)

    • 8.5 Japan Metabolic Syndrome Consumption Forecast (2022-2028)

    • 8.6 India Metabolic Syndrome Consumption Forecast (2022-2028)

    • 8.7 South Korea Metabolic Syndrome Consumption Forecast (2022-2028)

    9 Global Metabolic Syndrome Market Outlook by Types and Applications to 2022

    • 9.1 Global Metabolic Syndrome Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Obesity Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Hypercholesterolemia Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Lysosomal storage diseases Consumption and Growth Rate (2017-2022)

    • 9.2 Global Metabolic Syndrome Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Metabolic Syndrome Market Outlook by Types and Applications to 2028

    • 10.1 Global Metabolic Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Obesity Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Hypercholesterolemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Lysosomal storage diseases Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Metabolic Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Metabolic Syndrome Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Metabolic Syndrome Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Metabolic Syndrome Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Metabolic Syndrome Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Metabolic Syndrome Market Competitive Analysis

    • 14.1 AstraZeneca

      • 14.1.1 AstraZeneca Company Details

      • 14.1.2 AstraZeneca Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca Metabolic Syndrome Product and Service

    • 14.2 Novo Nordisk

      • 14.2.1 Novo Nordisk Company Details

      • 14.2.2 Novo Nordisk Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novo Nordisk Metabolic Syndrome Product and Service

    • 14.3 Eli Lily

      • 14.3.1 Eli Lily Company Details

      • 14.3.2 Eli Lily Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli Lily Metabolic Syndrome Product and Service

    • 14.4 Amicus Therapeutics

      • 14.4.1 Amicus Therapeutics Company Details

      • 14.4.2 Amicus Therapeutics Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amicus Therapeutics Metabolic Syndrome Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Metabolic Syndrome Product and Service

    • 14.6 Aegerion Pharmaceuticals

      • 14.6.1 Aegerion Pharmaceuticals Company Details

      • 14.6.2 Aegerion Pharmaceuticals Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Aegerion Pharmaceuticals Metabolic Syndrome Product and Service

    • 14.7 Alnylam Pharmaceuticals

      • 14.7.1 Alnylam Pharmaceuticals Company Details

      • 14.7.2 Alnylam Pharmaceuticals Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Alnylam Pharmaceuticals Metabolic Syndrome Product and Service

    • 14.8 Arbutus Biopharma

      • 14.8.1 Arbutus Biopharma Company Details

      • 14.8.2 Arbutus Biopharma Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Arbutus Biopharma Metabolic Syndrome Product and Service

    • 14.9 Actelion Pharmaceuticals

      • 14.9.1 Actelion Pharmaceuticals Company Details

      • 14.9.2 Actelion Pharmaceuticals Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Actelion Pharmaceuticals Metabolic Syndrome Product and Service

    • 14.10 Adocia

      • 14.10.1 Adocia Company Details

      • 14.10.2 Adocia Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Adocia Metabolic Syndrome Product and Service

    • 14.11 Merck

      • 14.11.1 Merck Company Details

      • 14.11.2 Merck Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Merck Metabolic Syndrome Product and Service

    • 14.12 Amarin

      • 14.12.1 Amarin Company Details

      • 14.12.2 Amarin Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amarin Metabolic Syndrome Product and Service

    • 14.13 nAmgen

      • 14.13.1 nAmgen Company Details

      • 14.13.2 nAmgen Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 nAmgen Metabolic Syndrome Product and Service

    • 14.14 AbbVie

      • 14.14.1 AbbVie Company Details

      • 14.14.2 AbbVie Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 AbbVie Metabolic Syndrome Product and Service

    • 14.15 Akros Pharma

      • 14.15.1 Akros Pharma Company Details

      • 14.15.2 Akros Pharma Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Akros Pharma Metabolic Syndrome Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Metabolic Syndrome

    • Figure Metabolic Syndrome Picture

    • Table Global Metabolic Syndrome Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metabolic Syndrome Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Metabolic Syndrome Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Metabolic Syndrome Consumption by Country (2017-2022)

    • Figure United States Metabolic Syndrome Consumption and Growth Rate (2017-2022)

    • Table Europe Metabolic Syndrome Consumption and Growth Rate (2017-2022)

    • Figure China Metabolic Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Japan Metabolic Syndrome Consumption and Growth Rate (2017-2022)

    • Figure India Metabolic Syndrome Consumption and Growth Rate (2017-2022)

    • Figure South Korea Metabolic Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic Syndrome Consumption Forecast by Country (2022-2028)

    • Figure United States Metabolic Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Metabolic Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Metabolic Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Metabolic Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Metabolic Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Metabolic Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Hypercholesterolemia Consumption and Growth Rate (2017-2022)

    • Figure Global Lysosomal storage diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypercholesterolemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lysosomal storage diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Metabolic Syndrome Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Metabolic Syndrome Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Metabolic Syndrome Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Metabolic Syndrome Product and Service

    • Table Eli Lily (Foundation Year, Company Profile and etc.)

    • Table Eli Lily Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lily Metabolic Syndrome Product and Service

    • Table Amicus Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Amicus Therapeutics Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amicus Therapeutics Metabolic Syndrome Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Metabolic Syndrome Product and Service

    • Table Aegerion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Aegerion Pharmaceuticals Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aegerion Pharmaceuticals Metabolic Syndrome Product and Service

    • Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Metabolic Syndrome Product and Service

    • Table Arbutus Biopharma (Foundation Year, Company Profile and etc.)

    • Table Arbutus Biopharma Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arbutus Biopharma Metabolic Syndrome Product and Service

    • Table Actelion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Actelion Pharmaceuticals Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Metabolic Syndrome Product and Service

    • Table Adocia (Foundation Year, Company Profile and etc.)

    • Table Adocia Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Adocia Metabolic Syndrome Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Metabolic Syndrome Product and Service

    • Table Amarin (Foundation Year, Company Profile and etc.)

    • Table Amarin Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amarin Metabolic Syndrome Product and Service

    • Table nAmgen (Foundation Year, Company Profile and etc.)

    • Table nAmgen Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table nAmgen Metabolic Syndrome Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Metabolic Syndrome Product and Service

    • Table Akros Pharma (Foundation Year, Company Profile and etc.)

    • Table Akros Pharma Metabolic Syndrome Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akros Pharma Metabolic Syndrome Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US